Dyskeratosis congenita: Molekuláris diagnosztika és terápiás lehetoségek

Translated title of the contribution: Molecular diagnosis and therapeutic measures in patients with dyskeratosis congenita

Zsolt D R Reiger, Gergely D R Varga, B. Tóth, L. Máródi, M. Erdős

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Dyskeratosis congenita is a rare genetically heterogeneous disorder characterized by bone marrow failure and premature ageing. Current knowledge on clinical manifestations, molecular pathomechanisms, diagnostic criteria and therapeutic possibilities of patients with dyskeratosis congenita are described. Mutation analysis of the gene encoding for dyskerin revealed the c.IVS2-5C>G splice site mutation. The importance of early diagnosis in order to prevent severe invasive infections and non-infectious complications is emphasized. Family screening is important to identify carriers as prenatal genetic diagnosis conveys great benefits for family planning.

Original languageHungarian
Pages (from-to)285-292
Number of pages8
JournalOrvosi Hetilap
Volume151
Issue number8
DOIs
Publication statusPublished - Feb 1 2010

Fingerprint

Dyskeratosis Congenita
Premature Aging
Mutation
Molecular Pathology
Family Planning Services
Prenatal Diagnosis
Early Diagnosis
Bone Marrow
Therapeutics
Infection
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dyskeratosis congenita : Molekuláris diagnosztika és terápiás lehetoségek. / Reiger, Zsolt D R; Varga, Gergely D R; Tóth, B.; Máródi, L.; Erdős, M.

In: Orvosi Hetilap, Vol. 151, No. 8, 01.02.2010, p. 285-292.

Research output: Contribution to journalArticle

@article{a14d1148891147619b8b580543e29de6,
title = "Dyskeratosis congenita: Molekul{\'a}ris diagnosztika {\'e}s ter{\'a}pi{\'a}s lehetos{\'e}gek",
abstract = "Dyskeratosis congenita is a rare genetically heterogeneous disorder characterized by bone marrow failure and premature ageing. Current knowledge on clinical manifestations, molecular pathomechanisms, diagnostic criteria and therapeutic possibilities of patients with dyskeratosis congenita are described. Mutation analysis of the gene encoding for dyskerin revealed the c.IVS2-5C>G splice site mutation. The importance of early diagnosis in order to prevent severe invasive infections and non-infectious complications is emphasized. Family screening is important to identify carriers as prenatal genetic diagnosis conveys great benefits for family planning.",
keywords = "Aplastic anemia, Dyskeratosis congenita, Dyskerin, Telomerase, Telomere",
author = "Reiger, {Zsolt D R} and Varga, {Gergely D R} and B. T{\'o}th and L. M{\'a}r{\'o}di and M. Erdős",
year = "2010",
month = "2",
day = "1",
doi = "10.1556/OH.2010.28811",
language = "Hungarian",
volume = "151",
pages = "285--292",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "8",

}

TY - JOUR

T1 - Dyskeratosis congenita

T2 - Molekuláris diagnosztika és terápiás lehetoségek

AU - Reiger, Zsolt D R

AU - Varga, Gergely D R

AU - Tóth, B.

AU - Máródi, L.

AU - Erdős, M.

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Dyskeratosis congenita is a rare genetically heterogeneous disorder characterized by bone marrow failure and premature ageing. Current knowledge on clinical manifestations, molecular pathomechanisms, diagnostic criteria and therapeutic possibilities of patients with dyskeratosis congenita are described. Mutation analysis of the gene encoding for dyskerin revealed the c.IVS2-5C>G splice site mutation. The importance of early diagnosis in order to prevent severe invasive infections and non-infectious complications is emphasized. Family screening is important to identify carriers as prenatal genetic diagnosis conveys great benefits for family planning.

AB - Dyskeratosis congenita is a rare genetically heterogeneous disorder characterized by bone marrow failure and premature ageing. Current knowledge on clinical manifestations, molecular pathomechanisms, diagnostic criteria and therapeutic possibilities of patients with dyskeratosis congenita are described. Mutation analysis of the gene encoding for dyskerin revealed the c.IVS2-5C>G splice site mutation. The importance of early diagnosis in order to prevent severe invasive infections and non-infectious complications is emphasized. Family screening is important to identify carriers as prenatal genetic diagnosis conveys great benefits for family planning.

KW - Aplastic anemia

KW - Dyskeratosis congenita

KW - Dyskerin

KW - Telomerase

KW - Telomere

UR - http://www.scopus.com/inward/record.url?scp=77249165125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77249165125&partnerID=8YFLogxK

U2 - 10.1556/OH.2010.28811

DO - 10.1556/OH.2010.28811

M3 - Article

C2 - 20153999

AN - SCOPUS:77249165125

VL - 151

SP - 285

EP - 292

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 8

ER -